Video Experimental Relacionado
Updated: Jan 28, 2026
08:01
Designing CAD/CAM Surgical Guides for Maxillary Reconstruction Using an In-house Approach
Published on: August 24, 2018
9.4K
Preocupaciones y desafíos en el diseño y las aplicaciones de nanovacunas guiadas por la clínica
Yuhong Gao1, Sijia Hua1, Xiulin Dong2,3
1Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou 310053, China.
Acta pharmaceutica Sinica. B
|January 26, 2026
Resumen
Las nanovacunas ofrecen una entrega de antígenos mejorada y una modulación de la respuesta inmunitaria en comparación con las vacunas convencionales. Superar los desafíos preclínicos es clave para traducir el potencial de las nanovacunas en aplicaciones clínicas para la prevención y el tratamiento de enfermedades.
Área de la Ciencia:
- Inmunología y Nanotecnología
- Ingeniería Biomédica
- Sistemas de Administración de Fármacos
Sus antecedentes:
- Las vacunas convencionales enfrentan limitaciones en eficacia y administración.
- La nanotecnología ofrece flexibilidad y control mejorados para el desarrollo de vacunas.
- Las nanovacunas optimizan la administración de antígenos y adyuvantes, mejorando las respuestas inmunitarias.
Objetivo del estudio:
- Revisar los conceptos de diseño, estrategias y aplicaciones de nanovacunas.
- Enfatizar los desafíos y las direcciones futuras para la traducción clínica de nanovacunas.
- Identificar los principios básicos para el desarrollo preclínico de nanovacunas.
Principales métodos:
- Revisión de la investigación actual sobre nanovacunas y estudios preclínicos.
- Análisis de las estrategias de diseño para la administración dirigida de antígenos y adyuvantes.
- Discusión de la modulación de las células inmunitarias por las plataformas de nanovacunas.
Principales resultados:
- Las nanovacunas demuestran un potencial significativo en modelos preclínicos.
- Se identificaron desafíos clave en la traducción clínica de nanovacunas.
- Se exploraron estrategias para superar los obstáculos preclínicos.
Conclusiones:
- Las nanovacunas representan una alternativa prometedora a las vacunas convencionales.
- Abordar los desafíos del desarrollo preclínico es crucial para el éxito clínico.
- Se necesita más investigación para facilitar la traducción de las nanovacunas en estrategias terapéuticas y preventivas.
Videos de Conceptos Relacionados
01:11Design Example: Application of Archimedes' Principle
828
Archimedes' principle is fundamental in analyzing the buoyant force and stability of floating bodies. In this example, a wooden block with a rectangular section floats in seawater. Based on the block's dimensions, its specific gravity and the specific weight of seawater are used to find the volume of water displaced and the center of buoyancy.
The volume of seawater displaced by the block is determined by first calculating the block's weight. This is done by multiplying the...
The volume of seawater displaced by the block is determined by first calculating the block's weight. This is done by multiplying the...
828
01:19Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
02:01Factorial Design
13.8K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.8K
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
1.4K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.4K
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
711
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
711
01:16Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
1.3K
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
1.3K